financetom
Business
financetom
/
Business
/
Update: Equifax Q1 Adjusted Earnings, Revenue Rise But Q2, Full-Year Guidance Trails Consensus; Shares Decline Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Equifax Q1 Adjusted Earnings, Revenue Rise But Q2, Full-Year Guidance Trails Consensus; Shares Decline Pre-Bell
Apr 18, 2024 3:39 AM

06:02 AM EDT, 04/18/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.)

Equifax's ( EFX ) shares slumped 9.1% in premarket activity on Thursday after the company's Q1 sales missed guidance, and its forecast for the full year also lagged market expectations.

The company reported Q1 adjusted earnings late Wednesday of $1.50 per diluted share, up from $1.43 a year earlier.

Analysts polled by Capital IQ expected $1.43.

Revenue in the quarter ended March 31 rose to $1.39 billion from $1.3 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.4 billion.

The company expects Q2 adjusted earnings of $1.65 to $1.75 per diluted share on revenue of $1.41 billion to $1.43 billion. Analysts surveyed by Capital IQ expect EPS of $1.87 on revenue of $1.44 billion.

The company expects 2024 adjusted earnings of $7.20 to $7.50 per diluted share on revenue of $5.67 billion to $5.77 billion. Analysts surveyed by Capital IQ expect EPS of $7.63 on revenue of $5.79 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Constellation Energy to buy Calpine in $26.6 billion deal
Constellation Energy to buy Calpine in $26.6 billion deal
Jan 10, 2025
(Reuters) - Constellation Energy ( CEG ) said on Friday it would buy privately held Calpine Corp, a geothermal and natgas energy company, in a cash-and-stock deal valued at $26.6 billion including debt, sending Constellation's shares up 3.3%. The deal comes as electricity demand is expected to rise to record highs this year, according to data from the U.S. Energy...
Walgreens Boots tops profit estimates as CEO's revamp efforts take hold
Walgreens Boots tops profit estimates as CEO's revamp efforts take hold
Jan 10, 2025
Jan 10 (Reuters) - Walgreens Boots Alliance ( WBA ) beat analysts' lowered expectations for first-quarter profit and maintained its annual forecast on Friday, as the healthcare company benefits from CEO Tim Wentworth's efforts to turn around its business. The company, which operates the second-biggest pharmacy chain in the U.S. and Boots stores in the UK, has launched multiple rounds...
Pacific Biosciences Launches Gut Health Test
Pacific Biosciences Launches Gut Health Test
Jan 10, 2025
07:01 AM EST, 01/10/2025 (MT Newswires) -- Pacific Biosciences of California ( PACB ) said Friday it launched GutID, the first commercial human gut health test. The company said the test combines Intus Bio's strain-level resolution assay and AI-driven analysis with the company's sequencing accuracy. Shares of the company rose nearly 5% in premarket activity. ...
Walgreens Boots tops profit estimates as turnaround efforts take hold
Walgreens Boots tops profit estimates as turnaround efforts take hold
Jan 10, 2025
(Reuters) - Walgreens Boots Alliance ( WBA ) beat analysts' lowered expectations for first-quarter profit and maintained its annual forecast on Friday, as the healthcare company benefits from CEO Tim Wentworth's efforts to turn around its business. The company's shares, which fell more than 60% in 2024, rose about 8.9% to $10.04 in premarket trading. The company, which operates the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved